E-Mail
IMAGE: Lead study author Jordana Hoppe, MD, a pediatric pulmonologist with Children s Hospital Colorado and assistant professor of pediatrics at the University of Colorado School of Medicine on the Anschutz Medical. view more
Credit: Children s Hospital Colorado
Children ages two to five who have the most common form of cystic fibrosis (CF), caused by two copies of the F508 gene mutation, have not had any modulator treatments available to them until recently. A new study authored by researchers at Children s Hospital Colorado and published May 6, 2021, in
Lancet Respiratory Medicine shows that the CFTR modulator - lumacaftor/ivacaftor - can be safe and well-tolerated for this age range for up to 120 weeks, allowing younger children to begin proactive treatment of CF earlier in their lives.
–This week Governor Gavin Newsom announced a series of initiatives building on the state’s work to "vaccinate California’s hard-to-reach communities against COVID-19, address vaccine hesitancy, and drive innovative efforts in the communities hardest hit by the pandemic."
The study assessed people’s knowledge of the virus in the earliest stages of the pandemic.
The study in
Current Medical Research & Opinion, surveyed 5,948 adults in Pennsylvania between March 25-31, 2020, and found that those who relied on social media and TV for news were less likely to get the facts right about the coronavirus.
In fact, adults that used Facebook as an additional source of news in any way were less likely to answer COVID-19 questions correctly than those who did not.
“The rise of social media has changed the way people around the world keep up with current events, with studies showing that up to 66% of Americans rely on social media for news,” says coauthor Robert Lennon, associate professor of family and community medicine at Penn State’s College of Medicine.
Governor announces new initiatives to expand vaccinations across California
Lake County News reports
05 May 2021
On Tuesday, Gov. Gavin Newsom announced a series of initiatives building on the state’s work to vaccinate California’s hard-to-reach communities against COVID-19, address vaccine hesitancy and drive innovative efforts in the communities hardest hit by the pandemic.
New efforts focus on direct appointment assistance; community outreach including neighborhood canvassing, phone banking and text banking; at-home vaccinations and transportation services; and an additional $33 million in funding, bringing the total to $85.7 million, to support community-based organizations.
“We’re at a pivotal moment in our COVID-19 vaccine rollout – more than 30 million doses have been administered in California to date, and it’s going to take some new approaches to reach those who haven’t been vaccinated yet,” said Governor Newsom. “These enhanced initiatives build o
Gabriela Popescu, professor
As highlighted in a
recent UBNow story, researchers and teams from UB’s Clinical and Translational Science Institute that previously implemented elements of team science in their work were far better prepared to navigate the changes wrought by COVID than those that did not.
CTSI Team Science Core Director Ekaterina I. Noye, professor of epidemiology and environmental health in the School of Public Health and Health Professions, says that one of the most notable UB researchers who has found success with a team science-based approach is Gabriela K. Popescu
, professor of biochemistry in the Jacobs School of Medicine and Biomedical Sciences.